Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Breast 2Thoracic 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 3137Triple Negative Breast Neoplasms 513Ovarian Neoplasms 226Colorectal Neoplasms 191Carcinoma, Non-Small-Cell Lung 190Prostatic Neoplasms 183Neoplasms 176Lung Neoplasms 164Neoplasm Metastasis 162Melanoma 118Stomach Neoplasms 114Pancreatic Neoplasms 112Endometrial Neoplasms 106Uterine Cervical Neoplasms 93Squamous Cell Carcinoma of Head and Neck 88Carcinoma, Intraductal, Noninfiltrating 82Head and Neck Neoplasms 81Colonic Neoplasms 81Sarcoma 63Breast Carcinoma In Situ 62Urinary Bladder Neoplasms 60Carcinoma, Renal Cell 60Motor Activity 59Esophageal Neoplasms 58Brain Neoplasms 50Lymphedema 44Breast Cancer Female 41Advanced Breast Cancer 40Liver Neoplasms 39HER2-positive Breast Cancer 38

Interventions

Tablets 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Breast × 1 year × Clear all
NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

NCT05721326 2026-01-13

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Abramson Cancer Center at Penn Medicine

Phase NA Completed
1,330 enrolled
BreastGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡